A comprehensive analysis of Aurora A; transcript levels are the most reliable in association with proliferation and prognosis in breast cancer
- PMID: 23627634
- PMCID: PMC3671980
- DOI: 10.1186/1471-2407-13-217
A comprehensive analysis of Aurora A; transcript levels are the most reliable in association with proliferation and prognosis in breast cancer
Abstract
Background: Aurora A kinase, a centrosomal serine/threonine kinase which plays an essential role in chromosome segregation during cell division, is commonly amplified and/or over expressed in human malignancies. Aurora A is suggested to be one of the proliferation parameters which is an independent prognostic factor for early invasive breast cancer patients; however the individual clinical or prognostic relevance of this gene has been a matter of debate.
Methods: A comprehensive analysis of Aurora A at the levels of gene expression, gene copy number and protein expression was performed for 278 primary invasive breast cancer patients; and the correlation with clinical outcomes were investigated.
Results: Aurora A gene expression level not only correlated with gene amplification, but was also significantly associated with several clinicopathological parameters and patient prognosis. Patients with higher nuclear grade, negative progesterone receptor status and higher Ki67 expressed higher levels of Aurora A mRNA, which was associated not only with poor relapse-free survival (RFS) but was also found to be a significant multivariate parameter for RFS. Aurora A protein expression was also significantly associated with clinicopathological characteristics; lymph node status, nuclear grade, estrogen receptor status and Ki67, but not with prognosis. By contrast, Aurora A gene amplification correlated with tumor size, nuclear grade and Ki67, and had no prognostic value.
Conclusion: Our data indicate that Aurora A gene expression is an effective tool, which defines both tumor proliferation potency and patient prognosis.
Figures




Similar articles
-
Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer.Br J Cancer. 2012 May 22;106(11):1798-806. doi: 10.1038/bjc.2012.167. Epub 2012 Apr 26. Br J Cancer. 2012. PMID: 22538974 Free PMC article.
-
Elevated Aurora B expression contributes to chemoresistance and poor prognosis in breast cancer.Int J Clin Exp Pathol. 2015 Jan 1;8(1):751-7. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 25755770 Free PMC article.
-
High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.BMC Cancer. 2013 Feb 1;13:47. doi: 10.1186/1471-2407-13-47. BMC Cancer. 2013. PMID: 23374458 Free PMC article.
-
Expression of YES-associated protein (YAP) and its clinical significance in breast cancer tissues.Hum Pathol. 2017 Oct;68:166-174. doi: 10.1016/j.humpath.2017.08.032. Epub 2017 Sep 9. Hum Pathol. 2017. PMID: 28899737 Review.
-
Prognostic value of ERCC1 mRNA expression in non-small cell lung cancer, breast cancer, and gastric cancer in patients from Southern China.Int J Clin Exp Pathol. 2014 Dec 1;7(12):8312-21. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25674197 Free PMC article. Review.
Cited by
-
Targeting aurora kinases as a potential prognostic and therapeutical biomarkers in pediatric acute lymphoblastic leukaemia.Sci Rep. 2020 Dec 4;10(1):21272. doi: 10.1038/s41598-020-78024-8. Sci Rep. 2020. PMID: 33277547 Free PMC article.
-
Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancer.Int J Oncol. 2015 Apr;46(4):1498-506. doi: 10.3892/ijo.2015.2842. Epub 2015 Jan 22. Int J Oncol. 2015. PMID: 25625960 Free PMC article.
-
AurkA controls self-renewal of breast cancer-initiating cells promoting wnt3a stabilization through suppression of miR-128.Sci Rep. 2016 Jun 24;6:28436. doi: 10.1038/srep28436. Sci Rep. 2016. PMID: 27341528 Free PMC article.
-
AURKA Increase the Chemosensitivity of Colon Cancer Cells to Oxaliplatin by Inhibiting the TP53-Mediated DNA Damage Response Genes.Biomed Res Int. 2020 Aug 10;2020:8916729. doi: 10.1155/2020/8916729. eCollection 2020. Biomed Res Int. 2020. PMID: 32851091 Free PMC article.
-
Aurora A is a prognostic marker for breast cancer arising in BRCA2 mutation carriers.J Pathol Clin Res. 2014 Nov 7;1(1):33-40. doi: 10.1002/cjp2.6. eCollection 2015 Jan. J Pathol Clin Res. 2014. PMID: 27499891 Free PMC article.
References
-
- Tanaka T, Kimura M, Matsunaga K, Fukada D, Mori H, Okano Y. Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res. 1999;59(9):2041–2044. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials